Kingdon Capital Management, L.L.C. Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Kingdon Capital Management, L.L.C.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $1.03 Million - $1.67 Million	-150,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $1.16 Million - $5.57 Million	150,000 New	150,000 $1.47 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.